申请人:Pfizer Products Inc.
公开号:EP1033366A3
公开(公告)日:2000-12-27
A compound of the formula: wherein: K is phenyl, 2-pyridyl. 3-pyridyl or 4-pyridyl, each ring optionally substituted with one to three substituents selected from halogen, C1-C3alkyl, C1-C3perfluoroalkyl, C1-C3alkoxy and C1-C3perfluoroalkoxy; L is H, C3-C8cycloalkyl, phenyl, 2-pyridyl, 3-pyridyl or 4-pyridyl; wherein each phenyl and pyridyl ring may be substituted with one to three substituents selected from C1-C3alkyl, C1-C3alkoxy and halogen;Z IS -COR3, -CONR1R2, -NR1R2 and SO2R4;X and Y are CH or N, with the proviso that one of X and Y must be CH;n is an integer from 0 to 3;m and p are independently selected from the integers 1 to 3;Q is O, NR, CHR;R is hydrogen or C1-C6alkyl;R1 and R2 are independently selected from hydrogen, C1-C6alkyl, (CH2)mphenyl, (CH2)mpyridyl, or R1 and R2 may be taken together with the nitrogen to which they are attached to form a 4 to 8 numbered ring optionally containing O, NH or NR;R3 is C1-C6alkyl; R4 is -NR1R2, -NH(CH2)mphenyl, -N(C4-C8cycloalkyl)2 and -NH(C4-C8cycloalkyl); or a pharmaceutically acceptable salt thereof.The compound is a neuropeptide Y antagonist and is effective in treating feeding disorders, cardiovascular diseases and other physiological disorders.
一个化合物的公式:其中:K是苯基,2-吡啶基,3-吡啶基或4-吡啶基,每个环可选择地用从卤素,C1-C3烷基,C1-C3全氟烷基,C1-C3烷氧基和C1-C3全氟烷氧基中选择的一个到三个取代基取代;L是H,C3-C8环烷基,苯基,2-吡啶基,3-吡啶基或4-吡啶基;其中每个苯基和吡啶基环可用从C1-C3烷基,C1-C3烷氧基和卤素中选择的一个到三个取代基取代;Z是-COR3,-CONR1R2,-NR1R2和SO2R4;X和Y是CH或N,条件是X和Y中的一个必须是CH;n是从0到3的整数;m和p是独立地从整数1到3中选择的;Q是O,NR,CHR;R是氢或C1-C6烷基;R1和R2是独立地从氢,C1-C6烷基,(CH2)m苯基,(CH2)m吡啶基中选择,或R1和R2可以与它们连接的氮一起形成一个含有O,NH或NR的4到8编号环;R3是C1-C6烷基;R4是-NR1R2,-NH(CH2)m苯基,-N(C4-C8环烷基)2和-NH(C4-C8环烷基);或其药学上可接受的盐。该化合物是一种神经肽Y拮抗剂,对治疗进食障碍,心血管疾病和其他生理障碍有效。